Apyx Medical Corporation
US ˙ NasdaqGS ˙ US03837C1062

SecurityAPYX / Apyx Medical Corporation
InstitutionMorgan Stanley
Latest Disclosed Ownership51,627 shares
Latest Disclosed Value $ 190,504
Morgan Stanley reports 114.50% increase in ownership of APYX / Apyx Medical Corporation

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 51,627 shares of Apyx Medical Corporation (US:APYX) valued at $190,504 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 24,069 shares of Apyx Medical Corporation. This represents a change in shares of 114.50% during the quarter. The current value of the position is $195,666 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F APYX MEDICAL COM 03837C106 51,627 27,558 114.50 191 126.19 0.0000
2026-05-27 2025-12-31 13F/A-1 APYX MEDICAL COM 03837C106 24,069 10,404 76.14 84 189.66 0.0000
2026-02-13 2025-12-31 13F APYX MEDICAL COM 03837C106 24,069 10,404 84 0.0000
2026-05-27 2025-09-30 13F/A-1 APYX MEDICAL COM 03837C106 13,665 0 0.00 29 -3.33 0.0000
2025-11-14 2025-09-30 13F APYX MEDICAL COM 03837C106 13,665 0 29 0.0000
2025-08-15 2025-06-30 13F APYX MEDICAL COM 03837C106 13,665 -392 -2.79 31 57.89 0.0000
2025-05-15 2025-03-31 13F APYX MEDICAL COM 03837C106 14,057 -1,400 -9.06 19 -20.83 0.0000
2025-05-15 2024-12-31 13F/A-1 APYX MEDICAL COM 03837C106 15,457 -386 -2.44 24 26.32 0.0000
2025-02-14 2024-12-31 13F APYX MEDICAL COM 03837C106 15,457 -386 24 0.0000
2025-05-14 2024-09-30 13F/A-2 APYX MEDICAL COM 03837C106 15,843 -1,450 -8.38 20 -17.39 0.0000
2025-02-14 2024-09-30 13F/A-1 APYX MEDICAL COM 03837C106 15,843 -1,450 20 0.0000
2024-11-14 2024-09-30 13F APYX MEDICAL COM 03837C106 15,843 -1,450 20 0.0000
2025-05-14 2024-06-30 13F/A-2 APYX MEDICAL COM 03837C106 17,293 -2,653 -13.30 23 -14.81 0.0000
2024-10-17 2024-06-30 13F/A-1 APYX MEDICAL COM 03837C106 17,293 -2,653 23 0.0000
2024-08-14 2024-06-30 13F APYX MEDICAL COM 03837C106 17,293 -2,653 23 0.0000
2024-10-17 2024-03-31 13F/A-2 APYX MEDICAL COM 03837C106 19,946 2,800 16.33 27 -38.64 0.0000
2024-08-16 2024-03-31 13F/A-1 APYX MEDICAL COM 03837C106 19,946 2,800 27 0.0000
2024-05-15 2024-03-31 13F APYX MEDICAL COM 03837C106 19,946 2,800 27 0.0000
2024-08-16 2023-12-31 13F/A-1 APYX MEDICAL COM 03837C106 17,146 -1,260 -6.85 45 -24.14 0.0000
2024-02-13 2023-12-31 13F APYX MEDICAL COM 03837C106 17,146 -1,260 45 0.0000
2023-11-15 2023-09-30 13F APYX MEDICAL COM 03837C106 18,406 1,988 12.11 59 -29.27 0.0000
2023-08-14 2023-06-30 13F APYX MEDICAL COM 03837C106 16,418 -166,697 -91.03 83 -84.44 0.0000
2023-05-15 2023-03-31 13F APYX MEDICAL COM 03837C106 183,115 -97,406 -34.72 527 -19.66 0.0001
2023-02-14 2022-12-31 13F APYX MEDICAL COM 03837C106 280,521 236,027 530.47 656 228.00 0.0001
2022-11-14 2022-09-30 13F APYX MEDICAL COM 03837C106 44,494 -2,136 -4.58 200 -26.47 0.0000
2022-10-27 2022-06-30 13F/A-1 APYX MEDICAL COM 03837C106 46,630 28,433 156.25 272 128.57 0.0000
2022-08-15 2022-06-30 13F APYX MEDICAL COM 03837C106 46,630 28,433 272 0.0000
2022-10-27 2022-03-31 13F/A-1 APYX MEDICAL COM 03837C106 18,197 -14,677 -44.65 119 -71.80 0.0000
2022-05-13 2022-03-31 13F APYX MEDICAL COM 03837C106 18,197 -14,677 119 0.0000
2022-02-14 2021-12-31 13F APYX MEDICAL COM 03837C106 32,874 -22,169 -40.28 422 -44.62 0.0001
2021-11-15 2021-09-30 13F APYX MEDICAL COM 03837C106 55,043 -10,115 -15.52 762 13.22 0.0001
2021-08-23 2021-06-30 13F/A-1 APYX MEDICAL COM 03837C106 65,158 52,783 426.53 673 460.83 0.0001
2021-08-16 2021-06-30 13F APYX MEDICAL COM 03837C106 65,158 52,783 673 0.0000
2021-05-17 2021-03-31 13F APYX MEDICAL COM 03837C106 12,375 -30,297 -71.00 120 -61.04 0.0000
2021-02-16 2020-12-31 13F APYX MEDICAL COM 03837C106 42,672 34,648 431.80 308 710.53 0.0000
2020-11-13 2020-09-30 13F APYX MEDICAL COM 03837C106 8,024 -7,403 -47.99 38 -55.29 0.0000
2020-08-14 2020-06-30 13F APYX MED COM 03837C106 15,427 7,219 87.95 85 193.10 0.0000
2020-05-26 2020-03-31 13F/A-1 APYX MED COM 03837C106 8,208 -44,251 -84.35 29 -93.47 0.0000
2020-05-15 2020-03-31 13F APYX MED COM 03837C106 8,208 -44,251 29 2.2278
2020-02-14 2019-12-31 13F APYX MED COM 03837C106 52,459 -73,997 -58.52 444 -48.13 0.0001
2019-11-14 2019-09-30 13F APYX MED COM 03837C106 126,456 117,757 1,353.68 856 1,375.86 0.0002
2019-08-14 2019-06-30 13F APYX MED COM 03837C106 8,699 -3,617 -29.37 58 -25.64 0.0000
2019-05-15 2019-03-31 13F APYX MED COM 03837C106 12,316 7,559 158.90 78 151.61 0.0000
2019-02-14 2018-12-31 13F BOVIE MEDICAL COM 10211F100 4,757 -11,751 -71.18 31 -73.50 0.0000
2019-04-23 2018-09-30 13F/A-2 BOVIE MEDICAL COM 10211F100 16,508 13,869 525.54 117 875.00 0.0000
2018-11-20 2018-09-30 13F/A-1 BOVIE MEDICAL COM 10211F100 16,508 0 117 0.0000
2018-11-14 2018-09-30 13F BOVIE MEDICAL COM 10211F100 16,508 13,869 117
2019-04-23 2018-06-30 13F/A-1 BOVIE MEDICAL COM 10211F100 2,639 -2,758 -51.10 12 -25.00 0.0000
2018-08-14 2018-06-30 13F BOVIE MEDICAL COM 10211F100 2,639 -2,758 12
2019-04-23 2018-03-31 13F/A-1 BOVIE MEDICAL COM 10211F100 5,397 -1,886 -25.90 16 -15.79 0.0000
2018-05-14 2018-03-31 13F BOVIE MEDICAL COM 10211F100 5,397 -1,886 16
2019-04-23 2017-12-31 13F/A-1 BOVIE MEDICAL COM 10211F100 7,283 -1,305 -15.20 19 -34.48 0.0000
2018-02-14 2017-12-31 13F BOVIE MEDICAL COM 10211F100 7,283 -1,305 19
2017-11-14 2017-09-30 13F BOVIE MEDICAL COM 10211F100 8,588 -95 -1.09 29 38.10 0.0000
2017-08-11 2017-06-30 13F BOVIE MEDICAL COM 10211F100 8,683 -1,212 -12.25 21 -22.22 0.0000
2017-05-22 2017-03-31 13F/A-1 BOVIE MEDICAL COM 10211F100 9,895 -3,886 -28.20 27 -44.90 0.0000
2017-05-12 2017-03-31 13F BOVIE MEDICAL COM 10211F100 9,895 27
2017-02-22 2016-12-31 13F/A-1 BOVIE MEDICAL COM 10211F100 13,781 7,459 117.98 49 48.48 0.0000
2017-02-13 2016-12-31 13F BOVIE MEDICAL COM 10211F100 13,781 49
2016-11-10 2016-09-30 13F BOVIE MEDICAL COM 10211F100 6,322 -378 -5.64 33 200.00 0.0000
2016-08-12 2016-06-30 13F BOVIE MEDICAL COM 10211F100 6,700 6,700 5.98 11 -66.67 0.0000
2015-02-13 2014-12-31 13F BOVIE MEDICAL COM 10211F100 0 -600 -100.00 0 -100.00
2014-12-16 2014-09-30 13F/A-1 BOVIE MEDICAL COM 10211F100 600 600 2 0.0000
2014-11-14 2014-09-30 13F BOVIE MEDICAL COM 10211F100 600 2 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.